BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dos Santos Viana I, Cordeiro Santos ML, Santos Marques H, Lima de Souza Gonçalves V, Bittencourt de Brito B, França da Silva FA, Oliveira E Silva N, Dantas Pinheiro F, Fernandes Teixeira A, Tanajura Costa D, Oliveira Souza B, Lima Souza C, Vasconcelos Oliveira M, Freire de Melo F. Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape. Expert Rev Vaccines 2021;20:989-99. [PMID: 34139141 DOI: 10.1080/14760584.2021.1945450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Schiller JT, Lowy DR. Prospects for preventing cancer with anti-microbial prophylactic vaccines. Cell Host & Microbe 2022. [DOI: 10.1016/j.chom.2022.10.016] [Reference Citation Analysis]
2 Yang H, Guan L, Hu B, Moreira L. Detection and Treatment of Helicobacter pylori: Problems and Advances. Gastroenterology Research and Practice 2022;2022:1-10. [DOI: 10.1155/2022/4710964] [Reference Citation Analysis]
3 Zou X, Hu J, Zhao M, Qin C, Zhu Y, Tian G, Cai J, Seeberger PH, Yin J. Chemical Synthesis of the Highly Sterically Hindered Core Undecasaccharide of Helicobacter pylori Lipopolysaccharide for Antigenicity Evaluation with Human Serum. J Am Chem Soc 2022. [PMID: 35939326 DOI: 10.1021/jacs.2c03068] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Hoft SG, Noto CN, DiPaolo RJ. Two Distinct Etiologies of Gastric Cancer: Infection and Autoimmunity. Front Cell Dev Biol 2021;9:752346. [PMID: 34900999 DOI: 10.3389/fcell.2021.752346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]